Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Interactive grand rounds: mood stabilizers in dementia.

Nelson JC, Tune LE, Daiello LA, Porsteinsson A.

Geriatrics. 2002 Sep;57(9):suppl 2-5. No abstract available.

PMID:
12271830
2.

[Psychopharmacological treatment of behavioral and psychological symptoms in dementia].

Lolk A, Gulmann NC.

Ugeskr Laeger. 2006 Oct 2;168(40):3429-32. Review. Danish.

PMID:
17032610
3.
4.

Pharmacotherapy for social anxiety disorder: an update.

Van Ameringen M, Mancini C, Patterson B, Simpson W.

Isr J Psychiatry Relat Sci. 2009;46(1):53-61. Review.

5.

Human teratogens: current controversies.

Frías JL, Gilbert-Barness E.

Adv Pediatr. 2008;55:171-211. Review. No abstract available.

PMID:
19048731
6.

Behavioral and psychological symptoms of dementia and medical treatment.

Amano N, Inuzuka S, Ogihara T.

Psychogeriatrics. 2009 Jun;9(2):45-9. doi: 10.1111/j.1479-8301.2009.00284.x. Review. No abstract available.

7.

Treating anxiety without SSRIs.

Zoberi K, Pollard CA.

J Fam Pract. 2010 Mar;59(3):148-54. No abstract available.

PMID:
20230732
8.

[ACE inhibitors for elderly hypertensive patients].

Landgraf W, Upmeyer HJ, Orengo P, Kugler J.

MMW Fortschr Med. 2000 Jan 27;142(4):41. German. No abstract available.

PMID:
10850097
9.

Treatment strategies for agitation and psychosis in dementia.

Tariot PN.

J Clin Psychiatry. 1996;57 Suppl 14:21-9. Review.

PMID:
9024333
10.

Pharmacotherapy of social anxiety disorder.

Ganasen KA, Stein DJ.

Curr Top Behav Neurosci. 2010;2:487-503. Review.

PMID:
21309123
11.

Behavioral symptoms in dementia: community-based research.

Auer SR, Monteiro IM, Reisberg B.

Int Psychogeriatr. 1996;8 Suppl 3:363-6; discussion 381-2. No abstract available.

PMID:
9154589
12.

Tube feeding can be discontinued by taking dopamine agonists and angiotensin-converting enzyme inhibitors in the advanced stages of dementia.

Yamaguchi H, Maki Y, Maki Y.

J Am Geriatr Soc. 2010 Oct;58(10):2035-6. doi: 10.1111/j.1532-5415.2010.03086.x. No abstract available.

PMID:
20929480
13.

Hypnopompic hallucinations during olanzapine treatment.

Mancinelli I, Pompili M, Ruberto A, Tatarelli R.

Can J Psychiatry. 2004 Jul;49(7):496-7. No abstract available.

PMID:
15362258
14.

Neonatal risks of maternal treatment with mood stabilizers.

Olfson M, Marcus S.

Arch Gen Psychiatry. 2007 Jul;64(7):866-7; author reply 867-8. No abstract available.

PMID:
17606821
15.

Frontotemporal dementia: a randomised, controlled trial with trazodone.

Lebert F, Stekke W, Hasenbroekx C, Pasquier F.

Dement Geriatr Cogn Disord. 2004;17(4):355-9.

PMID:
15178953
16.

[Leading drugs in 1995: success, failures and uncertainties].

Sternon J.

Rev Med Brux. 1995 Jul-Aug;16(4):311-7. French.

PMID:
7481249
17.

Paroxetine treatment of sexual disinhibition in dementia.

Stewart JT, Shin KJ.

Am J Psychiatry. 1997 Oct;154(10):1474. No abstract available.

PMID:
9326839
18.

Pharmacotherapy of post-traumatic stress disorder.

Ravindran LN, Stein MB.

Curr Top Behav Neurosci. 2010;2:505-25. Review.

PMID:
21309124
19.

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets.

de Haan L, van Amelsvoort T, Rosien K, Linszen D.

Psychopharmacology (Berl). 2004 Sep;175(3):389-90. No abstract available.

PMID:
15322727
20.

Treatment of a patient with dementia and inappropriate sexual behaviors with citalopram.

Chen ST.

Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):402-3. doi: 10.1097/WAD.0b013e3181ec16ec.

PMID:
20693867

Supplemental Content

Support Center